Autolus Therapeutics (AUTL) Non-Current Deffered Revenue (2021 - 2025)
Autolus Therapeutics' Non-Current Deffered Revenue came in at $253.44 million for Q1 2025, up 10.9% from $228.49 million a year earlier and up 3.6% from the prior quarter.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends
At the end of FY2024, Autolus Therapeutics' Non-Current Deffered Revenue was $244.6 million, up 43.1% from FY2023.
- Non-Current Deffered Revenue has increased in each of the last three years, with a three-year compound annual growth rate of 73.3% (FY2021 to FY2024).
- Going back by year, Non-Current Deffered Revenue was $170.9 million in FY2023 (+35.7%), $125.9 million in FY2022 (+167.8%) and $47.02 million in FY2021.
- The Q1 2025 figure represents the highest quarterly Non-Current Deffered Revenue in data going back to Q4 2021.
- Year-over-year, Non-Current Deffered Revenue has increased for ten consecutive quarters, with growth averaging 81.7% over the last eight quarters.
- The year-over-year growth in Non-Current Deffered Revenue has ranged between 10.9% (Q1 2025) and 168.4% (Q3 2023) over the last five years.
- Business Quant data shows AUTL's Non-Current Deffered Revenue at $244.6 million (Q4 2024), $248.94 million (Q3 2024) and $238.66 million (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Autolus Therapeutics | 688.78 Mn | -635.30 Mn | 25.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 253.44 Mn |
| Dec 31, 2024 | 244.60 Mn |
| Sep 30, 2024 | 248.94 Mn |
| Jun 30, 2024 | 238.66 Mn |
| Mar 31, 2024 | 228.49 Mn |
| Dec 31, 2023 | 170.90 Mn |
| Sep 30, 2023 | 140.78 Mn |
| Jun 30, 2023 | 135.76 Mn |
| Mar 31, 2023 | 130.81 Mn |
| Dec 31, 2022 | 125.90 Mn |
| Sep 30, 2022 | 52.44 Mn |
| Jun 30, 2022 | 50.62 Mn |
| Mar 31, 2022 | 48.81 Mn |
| Dec 31, 2021 | 47.02 Mn |
API Access
Autolus Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();